Day 3 | Opioids
Convening providers and community stakeholders come together to work toward the common goal of exceptional healthcare in Iowa and across the nation.
The Annual Forum sessions will benefit physicians, CEOs, CFOs, senior administrators, nurses, quality assurance professionals, trustees/ board members, clinic managers, infection control professionals, hospital pharmacy directors, clinical pharmacists and other healthcare personnel.
Welcome and Introduction
Medication for Addiction Treatment: If Not Now, When?
Overdose and opioid use disorder represent a clear and present public health emergency. Despite the availability of effective, approved medications for nearly 50 years the treatment system remains underdeveloped. This session will investigate the reason behind the slow adoption of treatments for OUD, investigate the compelling evidence for implementing treatment with Methadone, Buprenorphine and Naltrexone and discuss how hospitals and clinicians can implement MAT for the benefit of patients and communities.
- Describe the current American opioid epidemic and the urgent need to implement addiction treatment in hospitals and medical practices.
- Explain how to better understand and treat Opioid Use Disorders (Addiction).
- Discuss ways to apply MAT in practices and the benefits.
Engaging and Supporting Patients in Their Opioid Care Plans
The COVID-19 pandemic has spurred increases in usage of Telehealth for routine and urgent visits resulting in decreased cancellations and noshows. Whether in-person or through Telehealth, learn how motivational interviewing has helped clinicians and patients with opioid use disorders achieve first or next steps in a care plan.
- Outline the value of meeting patients where they are at physically and with their care plans.
- Explain how telehealth can be implemented with patients with opioid usage disorder.
- Demonstrate how motivational interviewing can be successfully initiated with patients with opioid use disorder.
- Construct a comprehensive approach for follow up to needs identified in Motivational Interviewing.
The Clinical Pharmacist Role in Substance Use Disorder Management in a Primary Care Clinic
In this session, Brianna McQuade will discuss the clinical pharmacist role within the interprofessional team approach to managing patients with substance use disorder. She will provide a background on pharmacist education, explain her specific position as a pharmacist working with patients with substance use disorders and complex medical histories, review patient cases highlighting her contributions, and provide recommendations for health systems to integrate pharmacists in their practices.
- Describe pharmacist training, expertise and skills that make them valuable members of the healthcare team.
- Explain the pharmacist role managing patients with substance use disorder.
- Review options for integrating pharmacists within the healthcare team.
Leaving in Action, Working Together
- Jennifer Brockman, MHA, BSN, RN, Chief Clinical Program Officer, Iowa Healthcare Collaborative, Des Moines
- Don Stader, MD, FACEP, Emergency Physician, Opioid Expert, Film Producer and Innovator, Golden, CO
- Pat Merryweather-Arges, Executive Director, Project Patient Care, Chicago, IL
- Brianna McQuade, PharmD, BCACP, MHPE, Clinical Pharmacist, Mile Square Health Center and Clinical Assistant Professor, University of Illinois at Chicago, College of Pharmacy, Chicago, IL
- Tom Evans, MD, President and CEO, Iowa Healthcare Collaborative, Des Moines